Evidence map›Paper›PMID 21841126›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Cytoplasmic Ig alpha serine/threonines fine-tune Ig alpha tyrosine phosphorylation and limit bone marrow plasma cell formation.

Heide Christine Patterson, Manfred Kraus, Donghai Wang, Aliakbar Shahsafaei, Joel M Henderson, Jane Seagal, Kevin L Otipoby, To-Ha Thai, Klaus Rajewsky

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Profiling the Atlantic Salmon IgMFrontiers in immunology · 2019
    Article
  4. γδ T cells affect IL-4 production and B-cell tolerance.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Heide Christine PattersonProgram in Cellular and Molecular Medicine at Children's Hospital Boston and Immune Disease Institute, Boston, MA 02115, USA.
Manfred Kraus
Donghai Wang
Aliakbar Shahsafaei
Joel M Henderson
Jane Seagal
Kevin L Otipoby
To-Ha Thai
Klaus Rajewsky
Boston Children's Hospital · USAbbott (United States) · USBeth Israel Deaconess Medical Center · USBiogen (United States) · USBoston University · USBrigham and Women's Hospital · US

Funding

BCR signaling during B cell development and maintenanceR37AI054636 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI CARROLL, MICHAEL CRAIG · 2003 to 2012
$5.7M
NIAID NIH HHS R37 AI054636
6 · The paper itself

Abstract

Igα serine 191 and 197 and threonine 203, which are located in proximity of the Igα ITAM, dampen Igα ITAM tyrosine phosphorylation. In this study, we show that mice with targeted mutations of Igα S191, 197, and T203 displayed elevated serum IgG2c and IgG2b concentrations and had elevated numbers of IgG2c- and IgG2b-secreting cells in the bone marrow. BCR-induced Igα tyrosine phosphorylation was slightly increased in splenic B cells. Our results suggest that Igα serine/threonines limit formation of IgG2c- and IgG2b-secreting bone marrow plasma cells, possibly by fine-tuning Igα tyrosine-mediated BCR signaling.

Indexed as

Amino Acid SequenceAnimalsBone Marrow CellsCell DifferentiationCell SeparationCytoplasmEnzyme-Linked Immunosorbent AssayFlow CytometryImmunoblottingMiceMice, Inbred C57BLMolecular Sequence DataMutationPhosphorylationPlasma CellsReceptors, Antigen, B-CellReceptors, Antigen, B-CellSerineThreonineTyrosine

Identifiers

PMID21841126
PMCPMC3169759
OpenAlexW2132456320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.